New nanomedicine candidates based on QUATSUV and NANOLIPOSOMESLearn more
The CLINAM Summit is a globally unique event that brings together all stakeholders in nanomedicine, targeted medicine and precision medicine. Our CEO Santi Sala has participated into the session Presentations on Nanoparticles – Analytics, Methods and Technologies by presenting the work Technology platform for the production of lipid-based nanovesicles as new nanomedicines. By this presentation he has described latest developments related to our projects Nano-Nafres...
08 Jun 2018 / by nanomol
18 Jan 2018 / by nanomol
23 Mar 2017 / by nanomol